ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260833.2	Tanespimycin	Pancreatic adenocarcinoma	0.020338227	Resistant
ENSG00000260833.2	Tanespimycin	Lymphoid neoplasm diffuse large B-cell lymphoma	0.012889656	Sensitive